Schrader Lab

Technological advances in precision oncology have primary focused on cancer treatment and detection of recurrent disease. Dr. Schrader’s program of research leverages precision oncology platforms to improve hereditary cancer detection, better differentiate hereditary versus non-hereditary forms of cancer, detect cancer earlier, and uncover germline variation that may not only confer increased cancer susceptibility, but may provide other significant information to the cancer patient, family and their care providers.